Cart (0 Items)
Your cart is currently empty.
View ProductsVarlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb - Research Grade |
|---|---|
| Source | CAS 1393344-72-3 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Varlilumab,1F5,CDX-1127,CD27, TNFRSF7,anti-CD27, TNFRSF7 |
| Reference | PX-TA1352 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb - Research Grade
General information on Anti-CD27/TNFRSF7[Homo sapiens] (Varlilumab) Monoclonal Antibody
Varlilumab has been investigated for the treatment of Melanoma, Skin Ulcer, Burkett’s Lymphoma, Mantle cell lymphoma, and T-cell Malignancy.
SDS-PAGE for Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb
Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
CD270 Recombinant Protein
PX-P4113 420€
Antigen
CD279 Recombinant Protein
PX-P4117 420€
Antigen
Human CD270,TNFRSF14,HVEM recombinant protein
PX-P4039 210€
Antigen
Human PDL1, B7-H1, CD274 recombinant protein
PX-P4038 210€
Antigen
Human Programmed cell death protein 1 recombinant protein (PDCD1)
PX-P4028 210€
Antigen
ICOS Protein – Human CD278 Recombinant Protein
PX-P4035 210€
ELISA
Varlilumab ELISA Kit
KPTX213 1300€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.